Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study:

Gudula J A M Boon, Yvonne M Ende-Verhaar, Roisin Bavalia, Lahassan H El Bouazzaoui, Marion Delcroix, Olga Dzikowska-Diduch, Menno V Huisman, Katarzyna Kurnicka, Albert T A Mairuhu, Saskia Middeldorp, Piotr Pruszczyk, Dieuwertje Ruigrok, Peter Verhamme, Hubert W Vliegen, Anton Vonk Noordegraaf, Joris W J Vriend, Frederikus A Klok

23 March, 2021

NZ Respiratory Research Review Issue 190

Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs:

Agathe Jouet, Cyril Gaudin, Nelly Badalato, Caroline Allix-Béguec, Stéphanie Duthoy, Alice Ferré, Maren Diels, Yannick Laurent, Sandy Contreras, Silke Feuerriegel, Stefan Niemann, Emmanuel André, Michel K. Kaswa, Elisa Tagliani, Andrea Cabibbe, Vanessa Mathys, Daniela Cirillo, Bouke C. de Jong, Leen Rigouts, Philip Supply

18 March, 2021

NZ Respiratory Research Review Issue 187

Provision of Smoking Cessation Resources in the Context of In-Person Shared Decision-Making for Lung Cancer Screening:

Jolie Shen, BS Kristina Crothers, MD Erin K. Kross, MD Kaylee Petersen, ARNP Anne C. Melzer, MD Mathhew Triplette, MD

18 March, 2021

NZ Respiratory Research Review Issue 193

The Use of Intrapleural Thrombolytic or Fibrinolytic Therapy, or Both, via Indwelling Tunneled Pleural Catheters With or Without Concurrent Anticoagulation Use:

Christopher R. Gilbert, DO, FCCP; Candice L. Wilshire, MD; Shu-Ching Chang, PhD; and Jed A. Gorden, MD, FCCP

18 March, 2021

NZ Respiratory Research Review Issue 196

The Airway Microbiota Modulates Effect of Azithromycin Treatment for Episodes of Recurrent Asthma-like Symptoms in Preschool Children: A Randomized Clinical Trial:

Jonathan Thorsen, Jakob Stokholm, Morten Arendt Rasmussen, Martin Steen Mortensen, Asker Daniel Brejnrod, Mathis Hjelmsø, Shiraz Shah, Bo Chawes, Klaus Bønnelykke, Søren Johannes Sørensen, and Hans Bisgaard

17 March, 2021

NZ Respiratory Research Review Issue 194

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial:

Prof Robert S Wallis, MD Sibuse Ginindza, MS Trevor Beattie, MSc Nishanee Arjun, BSc Morongwe Likoti, BS Vinodh A Edward, DTech et al.

16 March, 2021

NZ Respiratory Research Review Issue 199

Effect of Clear vs Standard Covered Masks on Communication With Patients During Surgical Clinic Encounters - A Randomized Clinical Trial:

Ian M. Kratzke, MD; Marcy E. Rosenbaum, PhD; Chase Cox, MD; David W. Ollila, MD; Muneera R. Kapadia, MD, MME

11 March, 2021

NZ Respiratory Research Review Issue 184

Diagnosis of pleural empyema/parapneumonic effusion by next-generation sequencing:

Yoshiki Shiraishi, Kirill Kryukov, Katsuyoshi Tomomatsu, Fumio Sakamaki,Shigeaki Inoue, So Nakagawa, Tadashi Imanishi & Koichiro Asano

9 March, 2021

NZ Respiratory Research Review Issue 184

Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia The SAFER Randomized Clinical Trial:

Jeffrey M. Pernica, MD; Stuart Harman, MD; April J. Kam, MD; Redjana Carciumaru, MSc; Thuva Vanniyasingam, PhD; Tyrus Crawford, BSocSc; Dale Dalgleish, RN, BHScN; Sarah Khan, MD; Robert S. Slinger, MD; Martha Fulford, MD; Cheryl Main, MD; Marek Smieja, MD, PhD; Lehana Thabane, PhD; Mark Loeb, MD

8 March, 2021

NZ Respiratory Research Review Issue 196

Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients:

Hannah R. Whittaker , Chloe Bloom, Ann Morgan , Deborah Jarvis, Steven J. Kiddle and Jennifer K. Quint

4 March, 2021

NZ Respiratory Research Review Issue 186